Catalent
CTLT
#1601
Rank
C$14.99 B
Marketcap
$82.63
Share price
-0.85%
Change (1 day)
77.92%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of June 2024 : C$6.83 Billion

According to Catalent's latest financial reports the company's total debt is C$6.83 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30C$6.43 B18.56%
2022-06-30C$5.43 B34.53%
2021-06-30C$4.03 B-2.53%
2020-06-30C$4.14 B6.64%
2019-06-30C$3.88 B8.55%
2018-06-30C$3.57 B32.43%
2017-06-30C$2.70 B12.29%
2016-06-30C$2.40 B3.08%
2015-06-30C$2.33 B-19.25%
2014-06-30C$2.89 B2.1%
2013-06-30C$2.83 B3.63%
2012-06-30C$2.73 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$55.6 M-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.46 B-93.15%๐Ÿ‡บ๐Ÿ‡ธ USA
C$8.05 B 17.76%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
C$0.31 B-95.45%๐Ÿ‡บ๐Ÿ‡ธ USA